JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB97205

Goat Anti-Human IgM mu chain (HRP)

Goat Anti-Human IgM mu chain (HRP)

Be the first to review this product! Submit a review

|

(28 Publications)

Suitable for ICC, IHC-P, ELISA, WB. Ideal for western blot. Cited in 28 publications.

查看别名

Immunoglobulin heavy constant mu, Ig mu chain C region, Ig mu chain C region BOT, Ig mu chain C region GAL, Ig mu chain C region OU, IGHM

关键信息

宿主种属

Goat

靶标种属

Human

靶标亚型

IgM

靶标特异性

Mu chain

最低交叉反应
预吸附

No

偶联物

HRP

激发波长/发射波长
应用

WB, ELISA, ICC, IHC-P

applications

克隆

Polyclonal

亚型

IgG

特异性

By immunoelectrophoresis and ELISA this antibody reacts specifically with Human IgM. Cross reactivity with other immunoglobulins and light chains is less than 0.1%.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ICC": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "IHC-P": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/200 - 1/2000", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/10000 - 1/100000", "notes":"<p>(as Primary).</p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/2000 - 1/25000", "notes":"<p>Colorimetric: 1/2000 - 1/20000; Chemiluminescent: 1/5000 - 1/25000</p>" } } }

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Immunogen
纯化说明
Antiserum was solid phase adsorbed to ensure class specificity. This antibody was isolated by affinity chromatography using antigen coupled to agarose beads and conjugated to Horse Radish Peroxidase (HRP).
存储溶液
pH: 6.8 - 7.4 Preservative: 0.05% CMIT/MIT based preservative Constituents: 0.2% BSA
运输条件
Blue Ice
推荐的短期储存条件
+4°C
推荐的长期储存条件
+4°C

产品实验方案

靶点信息

Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed : 20176268, PubMed : 22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed : 17576170, PubMed : 20176268).. Isoform 1. Constant region of secreted IgM (sIgM), also known as the Fc region of IgM antibody. Able to multimerize, forms high order polymers, mainly pentamers and occasionally hexamers, providing for multivalency and high avidity recognition of antigens (PubMed : 32029689, PubMed : 37095205). Natural sIgM are polyreactive and recognize conserved self- and pathogen-derived structures, whereas immune sIgM are secreted only upon exposure to pathogens and are antigen-specific. Both natural and immune sIgM are required for an efficient humoral immune response to infection (By similarity). Mediates sIgM effector functions mostly via Fc receptors and the complement system. On lymphoid cells binds high-affinity Fc receptor FCMR and promotes induction of an efficient neutralizing IgG response while maintaining tolerance to self-antigens. Recruits C1q complement component to initiate the classical complement pathway, facilitating the recognition and neutralization of pathogens by the host. Together with C1q and mannose-binding lectin promotes the phagocytosis of apoptotic cells by macrophages, ensuring the clearance of potential autoimmune epitopes from tissues (By similarity) (PubMed : 12847249, PubMed : 19006321, PubMed : 28230186, PubMed : 32029689). Involved in mucosal immunity. It is transported by transcytosis across mucosal epithelium by PIGR and secreted on the apical side in complex with PIGR secretory component to scan mucosal lining for pathogens. IgM-antigen complexes undergo FCMR-mediated retrotranscytosis across mucosal M cells toward antigen-presenting cells in mucosal lymphoid tissues (By similarity) (PubMed : 32029689).. Isoform 2. Constant region of membrane-bound IgM, part of the B cell receptor complex (BCR). IgM BCR provides constitutive tonic signaling for B cell survival. Mediates pre-BCR signaling that regulates B cell selection and rearrangement of Ig genes via allelic exclusion.
See full target information IGHM

文献 (28)

Recent publications for all applications. Explore the full list and refine your search

ImmunoHorizons 9: PubMed40557704

2025

ICAM-1 autoantibodies detected in healthy individuals and cross-react with functional epitopes.

Applications

Unspecified application

Species

Unspecified reactive species

Marc L Herman,Eric S Geanes,Rebecca McLennan,Gage J Greening,Heather Mwitanti,Todd Bradley

Acta pharmaceutica Sinica. B 14:4994-5007 PubMed39664439

2024

Exemplifying interspecies variation of liposome fate by the effects of anti-PEG antibodies.

Applications

Unspecified application

Species

Unspecified reactive species

Ercan Wu,Juan Guan,Yifei Yu,Shiqi Lin,Tianhao Ding,Yuxiu Chu,Feng Pan,Mengyuan Liu,Yang Yang,Zui Zhang,Jian Zhang,Changyou Zhan,Jun Qian

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 39:153-165 PubMed39614966

2024

Relevance of Neutralizing Antibodies for the Pharmacokinetics of Pegunigalsidase Alfa in Patients with Fabry Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Malte Lenders,Elise Raphaela Menke,Michael Rudnicki,Markus Cybulla,Eva Brand

Vaccines 12: PubMed39460299

2024

Maternal Preconception COVID-19 Vaccination and Its Protective Effect on Infants after a Breakthrough Infection during Pregnancy.

Applications

Unspecified application

Species

Unspecified reactive species

Yuting Yang,Jie Hu,Haijun Deng,Dapeng Chen,Guojin Wu,Huiwu Xing,Yuanyuan Liu,Shan Li,Yihan Yan,Ni Tang,Yao Zhao

Molecular & cellular proteomics : MCP 23:100783 PubMed38729610

2024

Circulating Autoantibody Profiling Identifies LIMS1 as a Potential Target for Pathogenic Autoimmunity in pathologic Myopia.

Applications

Unspecified application

Species

Unspecified reactive species

Jiao Qi,Hao Li,Yu Du,Yun Liu,Wenwen He,Jiaqi Meng,Ling Wei,Keke Zhang,Yi Lu,Xiangjia Zhu

Communications medicine 4:47 PubMed38491326

2024

Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severity.

Applications

Unspecified application

Species

Unspecified reactive species

Eric S Geanes,Rebecca McLennan,Cas LeMaster,Todd Bradley

Frontiers in immunology 14:1307429 PubMed38124744

2023

Immunogenicity of PE18, PE31, and PPE26 proteins from in humans and mice.

Applications

Unspecified application

Species

Unspecified reactive species

María García-Bengoa,Emil Joseph Vergara,Andy C Tran,Lorenzo Bossi,Andrea M Cooper,John E Pearl,Tufária Mussá,Maren von Köckritz-Blickwede,Mahavir Singh,Rajko Reljic

JCI insight 8: PubMed37490342

2023

Balance between maternal antiviral response and placental transfer of protection in gestational SARS-CoV-2 infection.

Applications

Unspecified application

Species

Unspecified reactive species

Juliana Gonçalves,Magda Melro,Marta Alenquer,Catarina Araújo,Júlia Castro-Neves,Daniela Amaral-Silva,Filipe Ferreira,José S Ramalho,Nádia Charepe,Fátima Serrano,Carlos Pontinha,Maria João Amorim,Helena Soares

Immunology and cell biology 101:857-866 PubMed37593973

2023

Serological assays to measure dimeric IgA antibodies in SARS-CoV-2 infections.

Applications

Unspecified application

Species

Unspecified reactive species

Zihui Wei,Fiona Angrisano,Emily M Eriksson,Ramin Mazhari,Huy Van,Shuning Zheng,Rob J Center,Irene Boo,James McMahon,Jillian Lau,Nicholas Kiernan-Walker,Shazia Ruybal-Pesántez,Ivo Mueller,Leanne J Robinson,David A Anderson,Heidi E Drummer

Nature communications 14:2179 PubMed37069158

2023

Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants.

Applications

Unspecified application

Species

Unspecified reactive species

Yubin Liu,Ziyi Wang,Xinyu Zhuang,Shengnan Zhang,Zhicheng Chen,Yan Zou,Jie Sheng,Tianpeng Li,Wanbo Tai,Jinfang Yu,Yanqun Wang,Zhaoyong Zhang,Yunfeng Chen,Liangqin Tong,Xi Yu,Linjuan Wu,Dong Chen,Renli Zhang,Ningyi Jin,Weijun Shen,Jincun Zhao,Mingyao Tian,Xinquan Wang,Gong Cheng
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com